|
C13ORF38 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.30629984396569E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.963900E-04 |
| Normal-vs-Stage3 |
1.73749903353837E-12 |
| Normal-vs-Stage4 |
3.023200E-01 |
| Stage1-vs-Stage2 |
6.939700E-02 |
| Stage1-vs-Stage3 |
5.093800E-01 |
| Stage1-vs-Stage4 |
2.811600E-01 |
| Stage2-vs-Stage3 |
1.315170E-01 |
| Stage2-vs-Stage4 |
6.770000E-01 |
| Stage3-vs-Stage4 |
3.300400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.55829843157585E-11 |
| Normal-vs-AfricanAmerican |
6.356000E-04 |
| Normal-vs-Asian |
3.386400E-02 |
| Caucasian-vs-AfricanAmerican |
4.212000E-01 |
| Caucasian-vs-Asian |
7.487600E-01 |
| AfricanAmerican-vs-Asian |
9.160400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.77319999478721E-08 |
| Normal-vs-Female |
1.64934732538313E-12 |
| Male-vs-Female |
3.432600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.88178419700125E-15 |
| Normal-vs-Age(41-60Yrs) |
6.27429999999762E-05 |
| Normal-vs-Age(61-80Yrs) |
1.62647673107585E-12 |
| Normal-vs-Age(81-100Yrs) |
7.29629999973724E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.167960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.275600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.745200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.753200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.704200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.894400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.176440E-02 |
| Normal-vs-Grade 2 |
1.11022302462516E-15 |
| Normal-vs-Grade 3 |
1.63358215843346E-12 |
| Normal-vs-Grade 4 |
4.854200E-01 |
| Grade 1-vs-Grade 2 |
8.912000E-01 |
| Grade 1-vs-Grade 3 |
8.687400E-01 |
| Grade 1-vs-Grade 4 |
3.173200E-01 |
| Grade 2-vs-Grade 3 |
1.503430E-01 |
| Grade 2-vs-Grade 4 |
2.050600E-01 |
| Grade 3-vs-Grade 4 |
2.846800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62481139653892E-12 |
| Normal-vs-ccB subtype |
1.29050103936379E-11 |
| ccA subtype-vs-ccB subtype |
2.699100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.002620E-04 |
| Normal-vs-N1 |
1.83339998738319E-09 |
| N0-vs-N1 |
2.070200E-01 |
|
|
